<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Aim </plain></SENT>
<SENT sid="1" pm="."><plain>The study was to investigate the metabolic profile of urine metabolites and to elucidate their clinical significance in patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Methods </plain></SENT>
<SENT sid="3" pm="."><plain><z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">Colorectal cancers</z:e> from early stage and advanced stage were used in this study </plain></SENT>
<SENT sid="4" pm="."><plain>Urine samples of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients and healthy adults were collected and subjected to capillary electrophoresis mass spectrometry based on moving reaction boundary analysis </plain></SENT>
<SENT sid="5" pm="."><plain>The metabolic data were analyzed by SPSS 17.0 to find urinary biomarkers for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Results </plain></SENT>
<SENT sid="7" pm="."><plain>The results indicated that the urine metabolic profiling of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients had significant changes compared with the <z:mpath ids='MPATH_458'>normal</z:mpath> controls, and there were also differences between early stage and advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients </plain></SENT>
<SENT sid="8" pm="."><plain>Compared with the control group, the levels of isoleucine, valine, arginine, <z:chebi fb="4" ids="24996">lactate</z:chebi> acid and leucine increased (P &lt; 0.05), but those of histidine, methionine, serine, aspartic acid, <z:chebi fb="14" ids="30769">citric acid</z:chebi>, succinate, and <z:chebi fb="0" ids="6650">malic acid</z:chebi> decreased in urine samples from <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="9" pm="."><plain>Furthermore, the levels of isoleucine and valine were lower in urine of patients with advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> than those in early stage <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (P &lt; 0.05) </plain></SENT>
<SENT sid="10" pm="."><plain>Conclusion </plain></SENT>
<SENT sid="11" pm="."><plain>The technique of capillary electrophoresis mass spectrometry based on MRB could reveal the significant metabolic alterations during progression of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and the method is feasible and may be useful for the early diagnosis of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
</text></document>